loader from loading.io

Anticoagulation in MCS

ACVC Cardio Talk

Release Date: 08/01/2024

Novel electrical therapies for patients with ADHF: a joint ACVC & EHRA Cardio Talk show art Novel electrical therapies for patients with ADHF: a joint ACVC & EHRA Cardio Talk

ACVC Cardio Talk

With Cecilia Linde, Karolinska Institute, Stockholm - Sweden and  Przemyslaw Mitkowski, Poznan University of Medical Sciences, Poznan - Poland. Modern approach to electrotherapy in ADHF: a joint ACVC & EHRA Cardio Talk.  

info_outline
Resuscitated cardiac arrest. What now? show art Resuscitated cardiac arrest. What now?

ACVC Cardio Talk

With Janine Poess, Heart Center of Leipzig, Leipzig - Germany, and Christian Hassager, Rigshospitalet, Copenhagen University Hospital, Copenhagen - Denmark. Janine Poess and Christian Hassager discuss prognostication after cardiac arrest.  

info_outline
Echocardiography in the MCS management show art Echocardiography in the MCS management

ACVC Cardio Talk

With Susanna Price, Royal Brompton Hospital, London - UK and Guido Tavazzi, University of Pavia, Pavia - Italy. Susanna Price and Guido Tavazzi discuss the challenges of echocardiographic assessment in patients with MCS support.

info_outline
Anticoagulation in MCS show art Anticoagulation in MCS

ACVC Cardio Talk

With Hannah Schaubroeck, ICU, Ghent University Hospital - Belgium, and Christophe Vandenbriele, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London - UK and OLV Hospital, Aalst - Belgium. Challenges associated with the anticoagulation and hemostasis disorders during MCS.

info_outline
No more beta-blockers after AMI? The results of the REDUCE-AMI trial show art No more beta-blockers after AMI? The results of the REDUCE-AMI trial

ACVC Cardio Talk

With Sean van Depen, University of Alberta, Edmonton - Canada, and Bertil Lindahl, Uppsala University, Uppsala - Sweden. Highlights from the REDUCE-AMI trial.

info_outline
What have we learned from the DanGer Shock trial? show art What have we learned from the DanGer Shock trial?

ACVC Cardio Talk

With David Morrow, Brigham and Women's Hospital, Boston - United States of America & Christian Hassager, Rigshospitalet - Copenhagen University Hospital, Copenhagen - Denmark. Results of a breakthrough study on circulatory support in patients with AMI-CS.

info_outline
Stress cardiomyopathies in the acute setting- what to do and what not to do show art Stress cardiomyopathies in the acute setting- what to do and what not to do

ACVC Cardio Talk

With Guido Tavazzi, University of Pavia, Pavia - Italy & Thomas Lüscher, Royal Brompton Hospital Imperial College London, London - United Kingdom of Great Britain & Northern. Aetiology and management of stress cardiomyopathies in acute settings. 

info_outline
Optimal timing for percutaneous MCS in cardiogenic shock show art Optimal timing for percutaneous MCS in cardiogenic shock

ACVC Cardio Talk

With Jacob Eifer Moller, Odense University Hospital, Odense - Denmark & Holger Thiele, Heart Center Leipzig at University of Leipzig, Leipzig - Germany.

info_outline
Cardiac biomarkers in non-cardiac surgery show art Cardiac biomarkers in non-cardiac surgery

ACVC Cardio Talk

With Christian Eugen Mueller, University Hospital Basel, Basel -Switzerland & Sigrun Halvorsen, Oslo University Hospital Ulleval, Oslo - Norway. Interdisciplinary approach to the patient: how to use clinical practice guidelines for perioperative patient consultations.   

info_outline
The use of diuretics in AHF show art The use of diuretics in AHF

ACVC Cardio Talk

With Agniezska Tycinska, Medical University of Bialystok, Bialystok - Poland, Frederik Verbrugge, University Hospital (UZ) Brussels, Brussels - Belgium & Ingo Ahrens, Hospital der Augustinerinnen, Cologne - Germany.  

info_outline
 
More Episodes

With Hannah Schaubroeck, ICU, Ghent University Hospital - Belgium, and Christophe Vandenbriele, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London - UK and OLV Hospital, Aalst - Belgium.

Challenges associated with the anticoagulation and hemostasis disorders during MCS.